Edwards Lifesciences Corp.
(NYSE : EW)

( )
EW PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.43%477.941.0%$753.43m
DHRDanaher Corp. -2.34%237.150.7%$651.68m
MDTMedtronic Plc 0.21%123.890.6%$614.52m
ABTAbbott Laboratories -0.91%121.440.8%$601.30m
ALGNAlign Technology, Inc. -0.12%594.936.3%$358.42m
ISRGIntuitive Surgical, Inc. -1.09%785.832.3%$347.03m
SYKStryker Corp. -0.52%252.251.3%$298.93m
NVCRNovoCure Ltd. -5.74%186.006.8%$279.45m
DXCMDexCom, Inc. 0.77%391.107.8%$277.48m
BDXBecton, Dickinson & Co. -0.24%250.111.0%$275.09m
BSXBoston Scientific Corp. 0.63%39.661.0%$244.85m
IDXXIDEXX Laboratories, Inc. -0.54%514.163.7%$223.91m
BAXBaxter International, Inc. -0.11%84.701.8%$220.94m
EWEdwards Lifesciences Corp. -0.26%86.220.4%$220.84m
AAgilent Technologies, Inc. -0.83%131.871.6%$187.81m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.